scientific program - ISoP : International Society of Pharmacovigilance

- SCIENTIFIC PROGRAM -Registration: 8.30 – 9.00LocationPatronageAcadémie Nationale de PharmacieSalle des Actes – Faculté de Pharmacie4, Avenue de l'Observatoire, 75006 ParisHealth Minister, FranceParis City Council, FranceNational Academy of Pharmacy, FranceAssistance Publique - Hôpitaux de Paris(AP-HP), FranceVerona University, ItalyReference Centre for Education andCommunication within the WHO Program forInternational Drug Monitoring, Verona, ItalyInternational Society of PharmacovigilanceOpening9.00 - François Chast, President of the National Academyof Pharmacy, Paris (France), Giampaolo Velo (Italy) &Hervé Le Louët (France)Ecopharmacovigilance – MeaningCo-Chairmen: Jean-Marie Haguenoer & Giampaolo Velo9.20 - Giampaolo Velo, Verona University, Verona (Italy) -Ecopharmacovigilance for a better health9.40 - Klaus Kummerer, Freiburg University, Freiburg(Germany) - Pharmaceuticals in the environment: knowingand managing the risks10.00 - Ettore Zuccato, Istituto Mario Negri, Milano (Italy)- Drug monitoring in the environment10.20 - Sara Karolak and Yves Levi, Paris-Sud 11University, Paris (France) – Quantitative risk assessmentof pharmaceuticals in waterExperiencesCo-Chairmen: Klaus Kummerer & Ake Wennmalm14.00 - Ake Wennmalm, Stockholm County Council,Stockholm (Sweden) - European experience14.20 - John Fawell, WHO Guidelines Committee,Geneve (Switzerland) - Drugs in drinking water: WHOApproach14.40 - Sylvie Crauste-Manciet, Paris DescartesUniversity, Paris (France) - Chemical contamination withantineoplastic drugs in hospital workplace15.00 - Brigitte Enriquez, Alfort National VeterinarySchool, Maison Alfort (France) - Veterinary drugs residuesand the environment15.20 - Marie-Hélène Loulergue, AFSSA (AgenceFrançaise de Sécurité Sanitaire des Aliments), Paris(France) - Medicinal products residues in water :prioritisation strategy for a national analysis campaignTarget AudienceHealth professionals (doctors, pharmacistsand nurses)Organizing CommitteeGiampaolo Velo, Verona University, ClinicalPharmacology Unit, Verona andPharmacovigilance Centre of Veneto Region,ItalyHervé Le Louët, Centre Régional dePharmacovigilance, Groupe hospitalier HenriMondor, AP-HP, Paris, FranceLocal CommitteeSamy Babai, Hélène Brocvielle, Silvia DosSantos, Centre Régional dePharmacovigilance, Groupe hospitalier HenriMondor, AP-HP, Paris, FranceDrug Industry10.40: Coffee BreakCo-Chairmen: Claire Sibenaler & David Taylor11.00 - David Taylor, WCA Environment, London (UnitedKingdom) – Ecopharmacovigilance: A perspective from theresearch based pharmaceutical industry11.20 - Laurent Auclert, Sanofi-Aventis, Paris (France) –Pharmaceuticals point of viewGreen PharmacyCo-Chaimen: James Clark & John Fawell11.40 - James Clark, York University (United Kingdom) -Green drugs12.00 - Maximilian Hempel, German EnvironmentalFoundation, Osnabrueck (Germany) - Green pharmacy:actual developments and future issues12.20 Discussion12.40 – 14.00: Lunch15.40: Coffee BreakRegulatory AgenciesCo-Chairmen: Hervé Le Louët & Jean-Marc Vidal16.00 - Jean-Marc Vidal, European Medicines Agency,London (United Kingdom) - The EMA approach16.20 - Charlotte Unger, Swedish Medical ProductsAgency, Uppsala (Sweden) - The need forecopharmacovigilance in a sustainable development forpharmaceuticals16.40 - Anette Kuester, German EnvironmentalProtection Agency, Dessau (Germany) – Pharmaceuticalauthorisation: strengthening environmental aspects17.00 DiscussionFinal Remarks17.20 - Paul Benkimoun, Journal Le Monde, Paris(France)Closing17.40 - Hervé Le Louët & Giampaolo Velo

SPEAKERS AND CHAIRMENLaurent Auclert, Sanofi-Aventis, Paris (France)Paul Benkimoun, Le Monde, Paris (France)François Chast, National Academy of Pharmacy,Paris (France)James Clark, York University (United Kingdom)Sylvie Crauste-Manciet, Paris Descartes University,Paris (France)Brigitte Enriquez, Alfort National Veterinary School,Maison Alfort (France)John Fawell, WHO Guidelines Committee, Geneve(Switzerland)Jean-Marie Haguenoer, National academy ofPharmacy, Paris (France)Maximilian Hempel, German EnvironmentalFoundation, Osnabrueck (Germany)Sara Karolak, Paris-Sud 11 University, Paris(France)Anette Kuester, German Environmental ProtectionAgency, Dessau (Germany)Klaus Kummerer, Freiburg University, Freiburg(Germany)Hervé Le Louët, Henri Mondor Hospital - AssistancePublique - Hôpitaux de Paris, Paris, (France)Yves Levi, Paris-Sud 11 University, Paris (France)Marie-Hélène Loulergue, Agence Française deSécurité Sanitaire des Aliments, Paris (France)Claire Sibenaler, Les Entreprises du Médicament,Paris (France)David Taylor, WCA Environment, London (UnitedKingdom)Charlotte Unger, Swedish Medical Products Agency,Uppsala (Sweden)Giampaolo Velo, Verona University, Verona (Italy)Jean-Marc Vidal, European Medicines Agency,London (United Kingdom)Ake Wennmalm, Stockholm County Council,Stockholm (Sweden)Ettore Zuccato, Istituto Mario Negri, Milan (Italy)We thankthe Institut de Recherches Internationales Servier(IRIS) andLes Entreprises du Médicament (LEEM)for their contributionSalle des ActesFaculté de Pharmacie4, Avenue de l'Observatoire75006 Paris4, Avenue del'ObservatoireFree Subscription(The seating is limited - early booking is recommended)Please contact the Local Committee- Until 14/09/2010 -Centre Régional de PharmacovigilanceHôpital Henri Mondor51 Avenue du Maréchal de Lattre de Tassigny94010 CRETEIL Cedex - FranceTel. : +33 1 49 81 47 00 Fax : +33 1 49 81 47 63Email: pharmacovigilance.henri-mondor@hmn.aphp.frWORKSHOPECOPHARMACOVIGILANCEWHICH FUTURE?21 Septembre 2010Académie Nationale de PharmacieParis